On Behalf Of The Cws Study Group

16PUBLICATIONS
30CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 19, 2023
Which Patients With Rhabdomyosarcoma Need Radiotherapy? Analysis of the Radiotherapy Strategies of the CWS-96 and CWS-2002P Studies and SoTiSaR Registry.

Ewa Koscielniak, Beate Timmermann, Marc Münter

|Jan 21, 2023
Developments in the Surgical Approach to Staging and Resection of Rhabdomyosarcoma.

Sheila Terwisscha van Scheltinga, Timothy Rogers, Naima Smeulders

|Feb 25, 2022
Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol.

Ewa Koscielniak, Bernd Blank, Christian Vokuhl

|Dec 10, 2021
A new valid rhabdomyosarcoma spheroid culture model for in vitro evaluation of hypericin-based photodynamic therapy.

Laura Hempfling, Anna Adamus, Benedikt R Wagner

|Oct 12, 2021
Infantile myofibromatosis: Excellent prognosis but also rare fatal progressive disease. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.

Monika Sparber-Sauer, Christian Vokuhl, Guido Seitz

|Sep 06, 2021
Children with progressive and relapsed pleuropulmonary blastoma: A European collaborative analysis.

Monika Sparber-Sauer, Arianna Tagarelli, Guido Seitz

Pageof 3

Frequent Collaborators

10 joint publications

Ruth Ladenstein

8 joint publications

Gustaf Ljungman

6 joint publications

Ewa Koscielniak

4 joint publications

Monika Scheer